CrioINOV II? New Mobile Therapy Products (Q2869406): Difference between revisions
Jump to navigation
Jump to search
(Changed an Item: Edited by the beneficiary bot - attach the beneficiary based on the string) |
(Removed claim: co-financing rate (P837): 79.0 percent, Removing co-finance rate from projects in portugal) |
||||||
| Property / co-financing rate | |||||||
| |||||||
| Property / co-financing rate: 79.0 percent / rank | |||||||
Revision as of 10:42, 13 September 2021
Project Q2869406 in Portugal
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | CrioINOV II? New Mobile Therapy Products |
Project Q2869406 in Portugal |
Statements
230,633.74 Euro
0 references
1 October 2016
0 references
31 March 2018
0 references
STEMLAB, S.A.
0 references
40°21'55.76"N, 8°39'29.95"W
0 references
O Projeto CrioINOV II ? Novos Produtos de Terapia Celular consiste num investimento de diversificação produtiva específico para criação de salas limpas classe B com condições GMP tendente a dotar a Stemlab de condições para desenvolvimento e produção de produtos de terapia celular. (Portuguese)
0 references
The CrioINOV II Project? New Mobile Therapy Products consists of a specific productive diversification investment for the creation of class B clean rooms with GMP conditions aimed at providing Stemlab with conditions for the development and production of mobile therapy products. (English)
7 July 2021
0 references
Cantanhede
0 references
Identifiers
CENTRO-02-0853-FEDER-022844
0 references